News
15h
Zacks.com on MSNShould You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
12d
Zacks.com on MSNWill Increased Expenses Affect Bristol Myers' Performance?Bristol Myers Squibb BMY announced a strategic collaboration agreement with BioNTech BNTX for the global co-development and ...
Sotyktu (deucravacitinib) has been assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 6, 2026.
4d
Zacks Investment Research on MSNBristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
Both companies have entered into an agreement for the global co-development and co-commercialization of BioNTech’s investigational bispecific antibody BNT327 across numerous solid tumor types.
Read about BioNTech SE ADR (BNTX:XNAS) stock and today's latest news and financial updates.
21d
Zacks Investment Research on MSNSMMT Stock Gains on Rumored Licensing Talks With AstraZenecaShares of clinical-stage company Summit Therapeutics SMMT rose nearly 9% on Thursday following a report issued by Bloomberg, which stated that pharma giant AstraZeneca AZN is in discussions with the ...
Bristol Myers is making waves after a period of pressure. The stock jumped 6.3% recently, outperforming its industry and the ...
Shares of clinical-stage company Summit Therapeutics SMMT rose nearly 9% on Thursday following a report issued by Bloomberg, which stated that pharma giant AstraZeneca AZN is in discussions with ...
Kim Jong-kook, the 'king of analog,' drew attention with his determined and planned approach, from navigating without a GPS to purchasing a property worth 6.2 billion won. In the episode of SBS's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results